Scott A Holmes's Net Worth
$1.89 Million
Who is Scott A Holmes?
Scott A Holmes has an estimated net worth of $1.89 Million. This is based on reported shares across multiple companies, which include AMAG PHARMACEUTICALS INC., and KERYX BIOPHARMACEUTICALS INC.
SEC CIK
Scott A Holmes's CIK is 0001537670
Past Insider Trading and Trends
2015 was Scott A Holmes's most active year for acquiring shares with 15 total transactions. Scott A Holmes's most active month to acquire stocks was the month of May. 2018 was Scott A Holmes's most active year for disposing of shares, totalling 10 transactions. Scott A Holmes's most active month to dispose stocks was the month of June. 2015 saw Scott A Holmes paying a total of $523,864.13 for 82,500 shares, this is the most they've acquired in one year. In 2015 Scott A Holmes cashed out on 33,387 shares for a total of $2,104,153.04, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AMAG PHARMACEUTICALS INC. No price found
SVP, Finance and TreasurerScott A Holmes owns 51,958 units of Common Stock.acquired a total of 82,600 shares in AMAG PHARMACEUTICALS INC. at a cost of $468,645.00, Scott also disposed a total of 35,392 shares of AMAG PHARMACEUTICALS INC. equalling to $2,181,050.91.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.53% | -1.35K |
$41.22 | -$406,421.14 | 51.96K |
Scheduled
|
Jun 15
| ||
Form 4/A
| +73.13% | 22.52K |
$16.43 | $370,010.74 | 53.3K |
Jun 3
| |||
Form 4
| -42.24% | -22.52K |
$68.88 | -$1,550,902.08 | 30.79K |
Jun 3
| |||
Form 4
| -0.99% | -533.00 |
$49.70 | -$26,490.10 | 53.3K |
Mar 3
| |||
Form 4
| +10.24% | 5K |
—
|
—
| 53.84K |
Feb 26
| |||
Form 4
| -1.73% | -859.00 |
$40.49 | -$34,780.91 | 48.84K |
Dec 17
| |||
Form 4
| +67.35% | 20K |
—
|
—
| 49.7K |
Aug 19
| |||
Form 4
| +102.07% | 15K |
—
|
—
| 29.7K |
Jun 11
| |||
Form 4
| +26.73% | 3.1K |
—
|
—
| 14.7K |
Feb 27
| |||
Form 4
| -5.34% | -654.00 |
$23.23 | -$15,192.42 | 11.6K |
Dec 16
| |||
Form 4
|
∞
| 7.5K |
—
|
—
| 7.5K |
Feb 28
| |||
Form 4
|
—
|
0
|
$14.79 | -$36,975.00 |
0
|
Scheduled
|
Dec 5
| ||
Form 4
|
—
|
0
|
$15.54 | -$11,655.00 |
0
|
Scheduled
|
Sep 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KERYX BIOPHARMACEUTICALS INC No price found
Chief Financial OfficerScott A Holmes used to own units in Common Stock but no longer holds any shares there. From 2015 to 2018 Scott A Holmes acquired a total of 153,750 shares in KERYX BIOPHARMACEUTICALS INC at a cost of $55,219.13, Scott also disposed a total of 206,250 shares of KERYX BIOPHARMACEUTICALS INC equalling to $231,431.18.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -162.96K |
—
|
—
|
0
|
Dec 12
| |||
Form 4
| -0.70% | -1.16K |
$2.77 | -$3,199.35 | 162.96K |
Nov 15
| |||
Form 4
| -0.76% | -1.25K |
$3.07 | -$3,849.78 | 164.11K |
Oct 29
| |||
Form 4
| -0.71% | -1.19K |
$3.04 | -$3,602.40 | 165.37K |
Aug 15
| |||
Form 4
| -1.39% | -2.35K |
$3.86 | -$9,086.44 | 166.55K |
Jul 30
| |||
Form 4
| -0.68% | -1.16K |
$5.69 | -$6,589.02 | 168.9K |
May 15
| |||
Form 4
| -1.40% | -2.41K |
$4.67 | -$11,240.69 | 170.06K |
Apr 30
| |||
Form 4
| +31.44% | 41.25K |
—
|
—
| 172.47K |
Mar 20
| |||
Form 4
| -4.13% | -5.65K |
$4.81 | -$27,181.31 | 131.22K |
Feb 15
| |||
Form 4
| -2.03% | -2.83K |
$4.81 | -$13,612.30 | 136.87K |
Jan 29
| |||
Form 4
| -1.81% | -2.58K |
$6.03 | -$15,569.46 | 139.7K |
Oct 30
| |||
Form 4
| -1.01% | -1.45K |
$7.14 | -$10,317.30 | 142.28K |
Jul 31
| |||
Form 4
| -0.85% | -1.24K |
$6.96 | -$8,602.56 | 143.73K |
Jul 28
| |||
Form 4
| -0.98% | -1.44K |
$5.97 | -$8,602.77 | 144.96K |
May 1
| |||
Form 4
| -0.83% | -1.22K |
$5.89 | -$7,179.91 | 146.4K |
Apr 28
| |||
Form 4
| +49.31% | 48.75K |
—
|
—
| 147.62K |
Feb 14
| |||
Form 4
| -7.87% | -8.45K |
$4.65 | -$39,278.55 | 98.87K |
Jan 30
| |||
Form 4
| -1.14% | -1.24K |
$4.44 | -$5,492.28 | 107.32K |
Oct 28
| |||
Form 4
| -4.35% | -4.93K |
$7.36 | -$36,321.60 | 108.56K |
Jul 29
| |||
Form 4
| +89.97% | 53.75K |
—
|
—
| 113.49K |
Jan 28
| |||
Form 4
| +9.13% | 5K |
$5.33 | $26,629.13 | 59.74K |
Nov 3 - Nov 4
| |||
Form 4
| +10.05% | 5K |
$5.72 | $28,590.00 | 54.74K |
Aug 21
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -5.25% | -2.76K |
$7.87 | -$21,705.46 | 49.74K |
Jul 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||